Hints and tips:
Related Special Reports
...Pfizer is “trying to leverage some of that brand equity that they got the world spinning again”, said Markus Saba, a marketing professor at the University of North Carolina Center for the Business of Health...
...For good reason: the US spent an estimated $4.5tn on healthcare services in 2022, according to the Centers for Medicare and Medicaid Services....
...“The biggest barrier is insurance companies,” said Lawrence Honig, a neurologist at New York’s Columbia University Irving Medical Center....
...Fake sugar under scrutiny In its filing on soda companies’ use of artificial sweeteners, the Interfaith Center on Corporate Responsibility, a coalition that coordinates investors, cited the World Health...
...“I think the responsibility ought to be entirely with Greg,” Buffett said from the stage at the CHI Health Center in downtown Omaha....
...He is expected to field dozens of questions from shareholders as he holds court for hours at the CHI Health Center, an arena in downtown Omaha, at Saturday’s meeting....
...“Vaccination remains critical to public health and continued protection against serious consequences of Covid-19, including hospitalisation and death,” said Peter Marks, director of the FDA’s Center for...
...Local boosters say there is more than meets the eye when it comes to Chicago’s commercial health....
...In 2020, the Center for Consumer Freedom, a non-profit group that has advocated for the meat, alcohol and tobacco industries, took aim at a new target: the plant-based meat industry Its Super Bowl television...
...of the FDA’s Center for Tobacco Products’ Office of Science....
...The drug will have a US list price of $26,500 a year, although health insurers will negotiate that down....
...The process is due to begin in earnest in September when the Centers for Medicare & Medicaid Services (CMS) is due to identify 10 expensive drugs that will be the focus of the negotiation....
...to an official tally published by the Centers for Medicare and Medicaid Services, a US government agency, last week....
...The high price of the drugs — lecanemab is priced at $26,500 per year — and tough restrictions imposed by the US government on reimbursement by publicly funded health schemes for amyloid-reducing treatments...
...Suicide among those aged between 10 and 19 years old in the US surged by 45.5 per cent between 2010 and 2020, according to the Centers for Disease Control and Prevention....
...UK financial regulator Ofwat is closely monitoring the financial health of Thames Water and Southern Water, among others, while S&P Global has negative outlooks for two-thirds of the water companies it rates...
...Buffett spent Saturday answering questions from shareholders that touched on estate planning, value investing, US-China relations and, more critical than any other to those assembled at the CHI Health Center...
...Health experts say the development of effective medicines to treat obesity that do not appear to have dangerous side effects is helping to ease concerns over weight loss drugs....
...Jeffrey Weber, principal investigator of the study and deputy director of the Perlmutter Cancer Center at NYU Langone, said the findings provided the first randomised evidence that a personalised neoantigen...
...A recent study co-funded by the Chinese Center for Disease Control and Prevention found that the country needed to make antivirals such as Paxlovid available to 160mn elderly people with underlying health...
...One of its biggest setbacks was the disastrous launch of aducanumab, which prompted the US Centers for Medicare & Medicaid Services to severely restrict reimbursement for all amyloid-reducing monoclonal...
...Defining companies’ responsibilities when it comes to political spending, lobbying and the wider health of democracy has been difficult....
...“Mental health is just as important as physical health,” he tweeted in January 2022....
...Ronald Petersen, director of the Mayo Clinic Alzheimer’s Disease Research Center, said if the lecanemab trial was a “flat-out negative” then it would not be good for the “amyloid hypothesis”....
International Edition